In April 2016 Manchester eScholar was replaced by the University of Manchester’s new Research Information Management System, Pure. All scholarly work records and full-texts stored in Manchester eScholar were migrated to the new system prior to this transition. From August 2016 the University’s research outputs will be available to view and download via the new Research Portal. Until then the old eScholar content WILL BE TEMPORARILY available to search and browse via this archive.

Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM)

Gibson, J M; Westwood, M; Young, R J; White, A

Journal of Clinical Endocrinology & Metabolism. 1996;81(2):860-863.

Access to files

Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:

Full-text held externally

Abstract

IGF-I and -II levels are altered in patients with atherogenic lipid profiles and may contribute to the development of macrovascular disease in NIDDM. We examined cardiovascular risk factors, IGF-I, IGF-II and IGFBP-1 in 74 NIDDM patients analysed as a whole group and according to treatment type. IGF-I was not significantly associated with cardiovascular risk factors but IGF-II levels correlated positively with total and LDL cholesterol most markedly in the diet treated group (0.72, p<0.01 and 0.76, p<0.01 respectively). In the whole group reduced IGFBP-1 levels were significantly associated with factors known to increase cardiovascular risk: i.e. low HDL cholesterol (0.31, p<0.01) and elevated blood pressure (-0.35, p<0.01), BMI (-0.37, p<0.01), insulin (-0.29, p<0.01) and proinsulin (-0.24, p<0.01). In the treatment groups IGFBP-1 was lower in patients on diet alone (n=11, 42.6+/-11.6 mu g/l) and sulphonylurea+insulin (n=39, 53.2+/-7.6 mu g/l) relative to insulin treatment (n=24, 103.0+/-19, 7 mu g/l, p<0.05). The lower levels of IGFBP-1 were not due to a significant change in phosphorylation status from the highly phosphorylated circulating form since lesser and non-phosphorylated variants were undetectable in 53/74 patients. Multiple regression analysis revealed the best predictors of IGFBP-1 were BMI and MAP (R(2) = 0.2. p<0.001) and for blood pressure, IGFBP-1 and age (R(2) = 0.47, p<0.001). These findings indicate that in NIDDM patients low IGFBP-1 levels are associated with multiple factors predisposing to atherogenesis.

Bibliographic metadata

Type of resource:
Content type:
Published date:
ISSN:
Volume:
81
Issue:
2
Start page:
860
End page:
863
Total:
4
Pagination:
860-863
ISI Accession Number:
ISI:A1996TU98100075
Related website(s):
  • Related website <Go to ISI>://A1996TU98100075
Access state:
Active

Institutional metadata

University researcher(s):

Record metadata

Manchester eScholar ID:
uk-ac-man-scw:151222
Created by:
Gibson, Martin
Created:
15th January, 2012, 15:04:10
Last modified by:
Gibson, Martin
Last modified:
1st February, 2013, 19:46:54

Can we help?

The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.